<p>美國市場在過去一週保持平穩，但在過去一年中顯著上漲了 30%，預計年收益增長將達到 16%。在這樣的環境下，內部持股比例高的成長型公司尤其吸引人，因為它們通常表明內部信心強烈，並與股東利益保持一致。</p>
<h3>美國內部持股比例高的十大成長型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股比例</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>優信 (UXIN)</td>
<td>35.7%</td>
<td>74.1%</td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>12.8%</td>
<td>53.6%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17%</td>
<td>53.2%</td>
</tr>
<tr>
<td>Enovix (ENVX)</td>
<td>12.4%</td>
<td>41.1%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>12%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>29.6%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>19.3%</td>
<td>104%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.8%</td>
<td>27.8%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>22.1%</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們快速增長的美國內部持股比例高的 203 只股票的完整列表。</p>
<p>在這裏，我們突出顯示了我們篩選器中一些首選股票的子集。</p>
<h2>Viemed Healthcare (VMD)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Viemed Healthcare, Inc. 在美國運營，提供家庭醫療設備和急性後呼吸健康服務，市值為 3.729 億美元。</p>
<p><strong>運營：</strong> 該公司從其醫療設施與服務部門產生的收入為 2.7028 億美元。</p>
<p><strong>內部持股比例：</strong> 13.6%</p>
<p><strong>收益增長預測：</strong> 每年 27.8%。</p>
<p>Viemed Healthcare 展現出作為一家內部持股比例高的成長型公司的潛力，過去一年其收益增長達到 32.6%，預計年收入增長為 12.8%，超過美國市場平均水平。該公司在最近的公告中強調了其對有機增長和有紀律的收購的戰略重點。此外，Viemed 的新股票回購計劃進一步表明了對其估值的信心，儘管最近沒有實質性的內部交易，其交易價格顯著低於估計的公允價值。</p>
<ul>
<li>在這裏深入瞭解 Viemed Healthcare 的具體情況，查看我們的詳細增長預測報告。</li>
<li>我們的估值報告揭示了 Viemed Healthcare 的股票可能在折扣交易。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a2a6ac4a-d3ae-4743-a8ab-bf92331843a7/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a2a6ac4a-d3ae-4743-a8ab-bf92331843a7/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 4 月的 VMD 收益和收入增長</p>
<h2>Ramaco Resources (METC)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Ramaco Resources, Inc. 從事冶金煤的開發、運營和銷售，市值為 8.8658 億美元。</p>
<p><strong>運營：</strong> 該公司的收入完全來自冶金煤部門，總計 5.3662 億美元。</p>
<p><strong>內部持股比例：</strong> 10.4%</p>
<p><strong>收益增長預測：</strong> 每年 93.4%。</p>
<p>Ramaco Resources 面臨挑戰，預計 2025 年淨虧損為 5145 萬美元，較前一年的淨收入 1119 萬美元下降，銷售數字也在下降。儘管面臨這些挫折，該公司交易價格顯著低於其估計的公允價值，預計在三年內將實現盈利，收益增長預測為每年 93.39%。然而，與集體訴訟相關的法律問題可能會影響投資者情緒，儘管最近沒有內部交易活動。</p>
<ul>
<li>點擊這裏發現 Ramaco Resources 的細微差別，查看我們的詳細分析未來增長報告。</li>
<li>根據我們的估值報告，Ramaco Resources 的股價可能偏低。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b401923f-33a5-4c09-8deb-b067999fa26b/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b401923f-33a5-4c09-8deb-b067999fa26b/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 4 月的 METC 收益和收入增長</p>
<h2>優信 (UXIN)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 優信有限公司是一家投資控股公司，在中華人民共和國作為二手車零售商運營，市值約為 6 億美元。</p>
<p><strong>運營：</strong> 該公司主要從其互聯網信息提供商部門產生的收入，總計為 32.4 億人民幣。</p>
<p><strong>內部持股比例：</strong> 35.7%</p>
<p><strong>收益增長預測：</strong> 每年 74.1%。</p>
<p>優信的增長軌跡得益於戰略擴張和高水平的內部持股，這使管理層的利益與股東保持一致。該公司報告 2025 年顯著的收入增長，達到 32.4 億人民幣，同時將淨虧損縮小至 2.7754 億人民幣。優信預計年收入增長為 36%，超過美國市場平均水平，並支持其在三年內的盈利前景。最近的領導層變動和戰略合作伙伴關係進一步增強了其在中國汽車行業的擴張。</p>
<ul>
<li>在我們的收益增長報告中更深入地瞭解優信的潛力。</li>
<li>我們最近的估值報告指出，優信的股票在市場上可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/ownership-breakdown"/></p>
<p>截至 2026 年 4 月的 UXIN 持股分佈</p>
<h2>利用機會</h2>
<ul>
<li>解鎖更多寶藏！我們的快速增長的美國內部持股比例高的公司篩選器為您挖掘了 200 家更多公司供您探索。點擊這裏揭示我們精心策劃的 203 家快速增長的美國內部持股比例高的公司的列表。</li>
<li>考慮其他策略？人工智能即將改變醫療保健。這 124 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——仍然有時間提前佈局。</li>
</ul>
<p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們基於歷史數據和分析師預測提供評論，採用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有預測的收入和收益增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</em></p>
<h3><strong>新功能：</strong> 在一個地方管理您的所有股票投資組合</h3>
<p>我們為股票投資者創建了 <strong>終極投資組合助手</strong>，<strong>而且是免費的。</strong></p>
<p>• 連接無限數量的投資組合，並以一種貨幣查看您的總額</p>
<p>• 通過電子郵件或手機接收新的警告信號或風險提示</p>
<p>• 跟蹤您股票的公允價值</p>
<p>免費試用演示投資組合</p>

METCB

METC

優信

<p>美國市場在過去一年中增長了 30%，預計年收益將增長 16%。擁有高內部持股的成長型公司頗具吸引力，表明內部信心強烈。值得注意的公司包括優信（35.7% 內部持股，74.1% 收益增長）、Ramaco Resources（10.4% 內部持股，93.4% 收益增長）和 Viemed Healthcare（13.6% 內部持股，27.8% 收益增長）。儘管面臨不同的挑戰，這些公司顯示出增長潛力，內部持股將管理層利益與股東利益對齊</p>

<p>The United States market remained flat over the last week but has seen a notable 30% increase over the past year, with earnings forecasted to grow by 16% annually. In such an environment, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment with shareholder interests.</p>
<div class="lb-trans"><p>美國市場在過去一週保持平穩，但在過去一年中顯著上漲了 30%，預計年收益增長將達到 16%。在這樣的環境下，內部持股比例高的成長型公司尤其吸引人，因為它們通常表明內部信心強烈，並與股東利益保持一致。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In The United States</h3>
<div class="lb-trans"><h3>美國內部持股比例高的十大成長型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Uxin (UXIN)</td>
<td>35.7%</td>
<td>74.1%</td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>12.8%</td>
<td>53.6%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17%</td>
<td>53.2%</td>
</tr>
<tr>
<td>Enovix (ENVX)</td>
<td>12.4%</td>
<td>41.1%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>12%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>29.6%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>19.3%</td>
<td>104%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.8%</td>
<td>27.8%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>22.1%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股比例</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>優信 (UXIN)</td>
<td>35.7%</td>
<td>74.1%</td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>12.8%</td>
<td>53.6%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17%</td>
<td>53.2%</td>
</tr>
<tr>
<td>Enovix (ENVX)</td>
<td>12.4%</td>
<td>41.1%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>12%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>29.6%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>19.3%</td>
<td>104%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.8%</td>
<td>27.8%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>22.1%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 203 stocks from our Fast Growing US Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們快速增長的美國內部持股比例高的 203 只股票的完整列表。</p>
</div><p>Here we highlight a subset of our preferred stocks from the screener.</p>
<div class="lb-trans"><p>在這裏，我們突出顯示了我們篩選器中一些首選股票的子集。</p>
</div><h2>Viemed Healthcare (VMD)</h2>
<div class="lb-trans"><h2>Viemed Healthcare (VMD)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Viemed Healthcare, Inc. operates in the United States offering home medical equipment and post-acute respiratory healthcare services, with a market cap of $372.90 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Viemed Healthcare, Inc. 在美國運營，提供家庭醫療設備和急性後呼吸健康服務，市值為 3.729 億美元。</p>
</div><p><strong>Operations:</strong> The company generates revenue of $270.28 million from its Healthcare Facilities &amp; Services segment.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司從其醫療設施與服務部門產生的收入為 2.7028 億美元。</p>
</div><p><strong>Insider Ownership:</strong> 13.6%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 13.6%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 27.8% p.a.</p>
<div class="lb-trans"><p><strong>收益增長預測：</strong> 每年 27.8%。</p>
</div><p>Viemed Healthcare demonstrates potential as a growth company with high insider ownership, evidenced by its robust earnings growth of 32.6% over the past year and forecasted revenue increase of 12.8% annually, surpassing the US market average. The company's strategic focus on organic growth and disciplined acquisitions was highlighted in recent announcements. Additionally, Viemed's new share repurchase program underscores confidence in its valuation, trading significantly below estimated fair value despite no substantial insider buying recently.</p>
<div class="lb-trans"><p>Viemed Healthcare 展現出作為一家內部持股比例高的成長型公司的潛力，過去一年其收益增長達到 32.6%，預計年收入增長為 12.8%，超過美國市場平均水平。該公司在最近的公告中強調了其對有機增長和有紀律的收購的戰略重點。此外，Viemed 的新股票回購計劃進一步表明了對其估值的信心，儘管最近沒有實質性的內部交易，其交易價格顯著低於估計的公允價值。</p>
</div><ul>
<li>Dive into the specifics of Viemed Healthcare here with our thorough growth forecast report.</li>
<li>Our valuation report unveils the possibility Viemed Healthcare's shares may be trading at a discount.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏深入瞭解 Viemed Healthcare 的具體情況，查看我們的詳細增長預測報告。</li>
<li>我們的估值報告揭示了 Viemed Healthcare 的股票可能在折扣交易。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a2a6ac4a-d3ae-4743-a8ab-bf92331843a7/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/a2a6ac4a-d3ae-4743-a8ab-bf92331843a7/chart/earnings-and-revenue-growth"/></p>
<p>VMD Earnings and Revenue Growth as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 VMD 收益和收入增長</p>
</div><h2>Ramaco Resources (METC)</h2>
<div class="lb-trans"><h2>Ramaco Resources (METC)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Ramaco Resources, Inc. is involved in the development, operation, and sale of metallurgical coal with a market cap of $886.58 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Ramaco Resources, Inc. 從事冶金煤的開發、運營和銷售，市值為 8.8658 億美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived entirely from the metallurgical coal segment, totaling $536.62 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司的收入完全來自冶金煤部門，總計 5.3662 億美元。</p>
</div><p><strong>Insider Ownership:</strong> 10.4%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 10.4%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 93.4% p.a.</p>
<div class="lb-trans"><p><strong>收益增長預測：</strong> 每年 93.4%。</p>
</div><p>Ramaco Resources faces challenges with a net loss of US$51.45 million for 2025, down from a net income of US$11.19 million the previous year, and declining sales figures. Despite these setbacks, the company is trading significantly below its estimated fair value and is expected to become profitable within three years with earnings growth forecasted at 93.39% annually. However, legal issues related to class action lawsuits could impact investor sentiment despite no recent insider trading activity.</p>
<div class="lb-trans"><p>Ramaco Resources 面臨挑戰，預計 2025 年淨虧損為 5145 萬美元，較前一年的淨收入 1119 萬美元下降，銷售數字也在下降。儘管面臨這些挫折，該公司交易價格顯著低於其估計的公允價值，預計在三年內將實現盈利，收益增長預測為每年 93.39%。然而，與集體訴訟相關的法律問題可能會影響投資者情緒，儘管最近沒有內部交易活動。</p>
</div><ul>
<li>Click here to discover the nuances of Ramaco Resources with our detailed analytical future growth report.</li>
<li>According our valuation report, there's an indication that Ramaco Resources' share price might be on the cheaper side.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏發現 Ramaco Resources 的細微差別，查看我們的詳細分析未來增長報告。</li>
<li>根據我們的估值報告，Ramaco Resources 的股價可能偏低。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b401923f-33a5-4c09-8deb-b067999fa26b/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/b401923f-33a5-4c09-8deb-b067999fa26b/chart/earnings-and-revenue-growth"/></p>
<p>METC Earnings and Revenue Growth as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 METC 收益和收入增長</p>
</div><h2>Uxin (UXIN)</h2>
<div class="lb-trans"><h2>優信 (UXIN)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Uxin Limited is an investment holding company that operates as a used car retailer in the People's Republic of China, with a market cap of approximately $600 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> 優信有限公司是一家投資控股公司，在中華人民共和國作為二手車零售商運營，市值約為 6 億美元。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from its Internet Information Providers segment, amounting to CN¥3.24 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司主要從其互聯網信息提供商部門產生的收入，總計為 32.4 億人民幣。</p>
</div><p><strong>Insider Ownership:</strong> 35.7%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 35.7%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 74.1% p.a.</p>
<div class="lb-trans"><p><strong>收益增長預測：</strong> 每年 74.1%。</p>
</div><p>Uxin's growth trajectory is underpinned by strategic expansions and a high level of insider ownership, which aligns management interests with shareholders. The company reported significant revenue growth for 2025, reaching CNY 3.24 billion, while narrowing its net loss to CNY 277.54 million. Uxin's forecasted annual revenue growth of 36% outpaces the US market average and supports its profitability outlook within three years. Recent leadership changes and strategic partnerships further bolster its expansion in China's automotive sector.</p>
<div class="lb-trans"><p>優信的增長軌跡得益於戰略擴張和高水平的內部持股，這使管理層的利益與股東保持一致。該公司報告 2025 年顯著的收入增長，達到 32.4 億人民幣，同時將淨虧損縮小至 2.7754 億人民幣。優信預計年收入增長為 36%，超過美國市場平均水平，並支持其在三年內的盈利前景。最近的領導層變動和戰略合作伙伴關係進一步增強了其在中國汽車行業的擴張。</p>
</div><ul>
<li>Take a closer look at Uxin's potential here in our earnings growth report.</li>
<li>Insights from our recent valuation report point to the potential overvaluation of Uxin shares in the market.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的收益增長報告中更深入地瞭解優信的潛力。</li>
<li>我們最近的估值報告指出，優信的股票在市場上可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/ownership-breakdown"/></p>
<p>UXIN Ownership Breakdown as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 UXIN 持股分佈</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用機會</h2>
</div><ul>
<li>Unlock more gems! Our Fast Growing US Companies With High Insider Ownership screener has unearthed 200 more companies for you to explore.Click here to unveil our expertly curated list of 203 Fast Growing US Companies With High Insider Ownership.</li>
<li>Contemplating Other Strategies? AI is about to change healthcare. These 124 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖更多寶藏！我們的快速增長的美國內部持股比例高的公司篩選器為您挖掘了 200 家更多公司供您探索。點擊這裏揭示我們精心策劃的 203 家快速增長的美國內部持股比例高的公司的列表。</li>
<li>考慮其他策略？人工智能即將改變醫療保健。這 124 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——仍然有時間提前佈局。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們基於歷史數據和分析師預測提供評論，採用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有預測的收入和收益增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：</strong> 在一個地方管理您的所有股票投資組合</h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我們為股票投資者創建了 <strong>終極投資組合助手</strong>，<strong>而且是免費的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 連接無限數量的投資組合，並以一種貨幣查看您的總額</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通過電子郵件或手機接收新的警告信號或風險提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟蹤您股票的公允價值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免費試用演示投資組合</p>
</div>

三家內部人士偏愛的高持股增長公司